415 related articles for article (PubMed ID: 12210822)
1. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
Kirkitadze MD; Bitan G; Teplow DB
J Neurosci Res; 2002 Sep; 69(5):567-77. PubMed ID: 12210822
[TBL] [Abstract][Full Text] [Related]
2. Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease.
Klein WL; Stine WB; Teplow DB
Neurobiol Aging; 2004; 25(5):569-80. PubMed ID: 15172732
[TBL] [Abstract][Full Text] [Related]
3. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key?
Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H
Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.
Kirkitadze MD; Kowalska A
Acta Biochim Pol; 2005; 52(2):417-23. PubMed ID: 15933761
[TBL] [Abstract][Full Text] [Related]
5. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
6. Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention.
Yang DS; Serpell LC; Yip CM; McLaurin J; Chrishti MA; Horne P; Boudreau L; Kisilevsky R; Westaway D; Fraser PE
Amyloid; 2001 Jul; 8 Suppl 1():10-9. PubMed ID: 11676284
[TBL] [Abstract][Full Text] [Related]
7. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
[TBL] [Abstract][Full Text] [Related]
8. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
9. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
Ha C; Park CB
Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
[TBL] [Abstract][Full Text] [Related]
10. Clusterin and Alzheimer's disease.
Calero M; Rostagno A; Frangione B; Ghiso J
Subcell Biochem; 2005; 38():273-98. PubMed ID: 15709484
[TBL] [Abstract][Full Text] [Related]
11. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
12. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
13. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
Dolev I; Michaelson DM
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
[TBL] [Abstract][Full Text] [Related]
14. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.
Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A
Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579
[TBL] [Abstract][Full Text] [Related]
15. Disruption of pathologic amyloid beta-protein fibril assembly on the surface of cultured human cerebrovascular smooth muscle cells.
Van Nostrand WE; Melchor JP
Amyloid; 2001 Jul; 8 Suppl 1():20-7. PubMed ID: 11676286
[TBL] [Abstract][Full Text] [Related]
16. Synaptic plasticity in animal models of early Alzheimer's disease.
Rowan MJ; Klyubin I; Cullen WK; Anwyl R
Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):821-8. PubMed ID: 12740129
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
Wyss-Coray T
J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
[TBL] [Abstract][Full Text] [Related]
19. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures.
Brendza RP; O'Brien C; Simmons K; McKeel DW; Bales KR; Paul SM; Olney JW; Sanes JR; Holtzman DM
J Comp Neurol; 2003 Feb; 456(4):375-83. PubMed ID: 12532409
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta aggregation.
Finder VH; Glockshuber R
Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
